Jeetinder Singh Mahal - Sep 24, 2021 Form 3 Insider Report for Jasper Therapeutics, Inc. (JSPR)

Role
Officer
Signature
By: /s/ Jeet Mahal
Stock symbol
JSPR
Transactions as of
Sep 24, 2021
Transactions value $
$0
Form type
3
Date filed
10/1/2021, 04:09 PM
Next filing
Mar 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding JSPR Voting Common Stock 110K Sep 24, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding JSPR Stock Option (right to buy) Sep 24, 2021 Common Stock 183K $0.71 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the original number of shares subject to the option vested on December 12, 2020, and 1/48th of the original number of shares have vested and shall vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date.

Remarks:

Title: Chief Financial Officer, Chief Business Officer and Corporate Secretary; Exhibit 24 - Power of Attorney